Evidence map›Paper›PMID 23200770›Full record

ArticleVirology2013

Heat shock protein 90AB1 and hyperthermia rescue infectivity of HIV with defective cores.

Pheroze Joshi, Barbara Sloan, Bruce E Torbett, Cheryl A Stoddart

Open access · hybridAbstract read
In one paragraph

Article in Virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Review
  6. Frontiers in immunology · 2023
    Article
  7. Review
  8. HSF1 Activation Can Restrict HIV Replication.ACS infectious diseases · 2020
    Article
  9. Article
  10. Article
  11. Inhibition of Heat Shock Protein 90 Prevents HIV Rebound.The Journal of biological chemistry · 2016
    Article
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Pheroze JoshiDivision of Experimental Medicine, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, CA 94110, USA.
Barbara Sloan
Bruce E Torbett
Cheryl A Stoddart
University of California, San Francisco · USSan Francisco General Hospital · USScripps Research Institute · US

Funding

Virology CoreP30AI027763 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI STEVEN Grant DEEKS · 1988 to 2026
$93.6M
VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Maile Ann Young Karris · 1994 to 2026
$78.4M
STRUCTURE-BASED MECHANISMS FOR RESISTANCE TO PROTEASE INHIBITORSP01GM083658 · NIGMS · SCRIPPS RESEARCH INSTITUTE, THE · PI OLSON, ARTHUR J. · 2008 to 2012
$9.6M
NIAID NIH HHS HHSN266200700002C/N01-AI-70002NIAID NIH HHS N01 AI070002NIAID NIH HHS P30 AI027763NIAID NIH HHS P30 AI036214NIAID NIH HHS P30AI036214NIGMS NIH HHS P01 GM083658
6 · The paper itself

Abstract

We previously showed that reduced infectivity of HIV with incompletely processed capsid-spacer protein 1 (CA-SP1) is rescued by cellular activation or increased expression of HSP90AB1, a member of the cytosolic heat shock protein 90 family. Here we show that HSP90AB1 is present in HIV virions and that HSP90AB1, but not nonfunctional mutated HSP90AB1(E42A+D88A), restores infectivity to HIV with mutations in CA that alter core stability. Further, the CA mutants were hypersensitive to pharmacological inhibition of HSP90AB1. In agreement with Roesch et al. (2012), we found that culturing HIV at 39.5°C enhanced viral infectivity up to 30-fold in human peripheral blood mononuclear cells (p=0.002) and rescued CA-mutant infectivity in nonactivated cells, concurrent with elevated expression of HSP90AB1 during hyperthermia. In sum, the transdominant effect of HSP90AB1 on CA-mutant HIV infectivity suggests a potential role for this class of cellular chaperones in HIV core stability and uncoating.

Indexed as

Capsid ProteinsCell LineHEK293 CellsHIVHot TemperatureHSP90 Heat-Shock ProteinsHumansJurkat CellsLeukocytes, MononuclearMutationT-LymphocytesViral Core ProteinsCapsid ProteinsHSP90AB1 protein, humanHSP90 Heat-Shock ProteinsViral Core Proteins

Identifiers

PMID23200770
PMCPMC3563299
OpenAlexW2073959802

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.